Access to medicines is a complex, but critical issue. SECTION27’s Tendai Mafuma and Nomatter Ndebele explore how the South African Health Products Regulatory Authority hinders or could potentially assist access to affordable medicines.
Depo-Testosterone, an affordable injectable hormone, has been out of stock in South Africa for more than three months. The shortage has been described as life-threatening. Karin Schimke reports.
The recent stock-out of a hormone used in gender-affirming treatment for transgender men has revealed a system-wide neglect of a large sector of the South African population. Karin Schimke reports.
An important new antiretroviral medicine will soon become available to people living with HIV in various Sub-Saharan African countries. Unfortunately, many women might be denied access to this new drug due to an inability of regulators and health departments to see potential risks associated with the drug in the proper context.